JOURNAL OF HEPATOCELLULAR CARCINOMA : Impact Factor & More
eISSN: 2253-5969pISSN: 2253-5969
Open AccessShare this on:
Key Metrics
Eigenfactor 
< 0.001
Impact Factor
< 5
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on JOURNAL OF HEPATOCELLULAR CARCINOMA
JOURNAL OF HEPATOCELLULAR CARCINOMA Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in JOURNAL OF HEPATOCELLULAR CARCINOMA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JOURNAL OF HEPATOCELLULAR CARCINOMA
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
- 25 Nov 2025
- Journal of Hepatocellular Carcinoma
Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Retrospective Study
- 24 Nov 2025
- Journal of Hepatocellular Carcinoma
Integrative Multi-Omics and Functional Validation Reveal the Role of the TACE Refractoriness-Associated Gene ATP1B3 in Hepatocellular Carcinoma
- 19 Nov 2025
- Journal of Hepatocellular Carcinoma
ARID3A Promotes Tumor Progression by Activating TNF-α/NF-κB Signaling in Dual-Phenotype Hepatocellular Carcinoma
- 19 Nov 2025
- Journal of Hepatocellular Carcinoma
CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy
- 19 Nov 2025
- Journal of Hepatocellular Carcinoma
SCD36 as a Biomarker for Progression and Recurrence in Type 2 Diabetes Mellitus Associated Hepatocellular Carcinoma
- 14 Nov 2025
- Journal of Hepatocellular Carcinoma
Machine Learning-Based Survival Analysis for Patients Receiving Lenvatinib for Unresectable Hepatocellular Carcinoma
- 25 Nov 2025
- Journal of Hepatocellular Carcinoma
Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Retrospective Study
- 24 Nov 2025
- Journal of Hepatocellular Carcinoma
Integrative Multi-Omics and Functional Validation Reveal the Role of the TACE Refractoriness-Associated Gene ATP1B3 in Hepatocellular Carcinoma
- 19 Nov 2025
- Journal of Hepatocellular Carcinoma
ARID3A Promotes Tumor Progression by Activating TNF-α/NF-κB Signaling in Dual-Phenotype Hepatocellular Carcinoma
- 19 Nov 2025
- Journal of Hepatocellular Carcinoma
CT-Based Radiomics-Clinical Model for Predicting Recurrence in VETC-Positive HCC Patients After Hepatectomy
- 19 Nov 2025
- Journal of Hepatocellular Carcinoma
SCD36 as a Biomarker for Progression and Recurrence in Type 2 Diabetes Mellitus Associated Hepatocellular Carcinoma
- 14 Nov 2025
- Journal of Hepatocellular Carcinoma
FAQs on JOURNAL OF HEPATOCELLULAR CARCINOMA
How long has JOURNAL OF HEPATOCELLULAR CARCINOMA been actively publishing? 
What is the publishing frequency of JOURNAL OF HEPATOCELLULAR CARCINOMA?
How many articles did JOURNAL OF HEPATOCELLULAR CARCINOMA publish last year?
What is the eISSN & pISSN for JOURNAL OF HEPATOCELLULAR CARCINOMA?
Who is the publisher of JOURNAL OF HEPATOCELLULAR CARCINOMA?
